1) In
of the original article, FGF10 concentration should be 50 ng/ml -as correctly stated in the Methods section -instead of 100 μg/ml. 2) Also in Fig. 1a of the original article, Activin A and EGF concentrations should both be 100 ng/ml -as correctly stated in the Methods section -instead of 100 μg/ml. 3) In the Methods section under the sub-heading "Differentiation of human pluripotent stem cells into pancreatic progenitor", the term, '50 ng/ml hFGF10' should be omitted from the following sentence:
"At the end of stage 3, media were changed to DMEM supplemented with 1% vol/vol B27, 0.25 mM vitamin C, 50 ng/ml hFGF10, 50 ng/ml hNOGGIN, 100 ng/ml hEGF, and 10 mM nicotinamide (Sigma, USA) for 4 days of stage 4 treatment for each protocol (Fig. 1a) ."
FGF10 was only added during stages 2 & 3 of differentiation as correctly depicted in Fig. 1a .
The corrected version of Fig. 1a can be viewed ahead.
